Staten Biotechnology, Novo Nordisk enter into a deal worth $430M

Staten Biotechnology has signed a dyslipidaemia licence option deal worth US$430 million with Novo Nordisk. Unde...

December 18, 2018 | Tuesday | News
Global Cannabis Partnership expands to 31 members

The Global Cannabis Partnership (GCP) is pleased to announce the addition of seven new Members as it continues to grow i...

December 18, 2018 | Tuesday | News
Orchard Therapeutics, SIRION Biotech partners for gene therapy

Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patien...

December 18, 2018 | Tuesday | News
Bristol-Myers Squibb receives positive CHMP Opinion recommending Sprycel for Pediatric Patients

Bristol-Myers Squibb Company has announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...

December 18, 2018 | Tuesday | News
Bristol-Myers Squibb, Boston Medical Centre announce collaboration

Bristol-Myers Squibb Company and Boston Medical centre, a private, not-for-profit, academic medical centre has announced...

December 18, 2018 | Tuesday | News
Merck launches new Steritest NEO Device

Merck has launched the latest evolution in sterility testing devices, the Steritest™ NEO device, which provides sa...

December 18, 2018 | Tuesday | News
Lilly to acquire Pre-Clinical Pain Program from Hydra Biosciences

Eli Lilly and Company has announced an agreement with Hydra Biosciences to acquire all assets related to Hydra's pre-cli...

December 17, 2018 | Monday | News
Lilly announces positive top-line results for Taltz

Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...

December 17, 2018 | Monday | News
Zymergen announces $400M in Series C Funding

Molecular manufacturing technology company, Zymergen has announced that it has raised over $400 million in Series C fund...

December 17, 2018 | Monday | News
The Changing API Industry

Growth in healthcare adoption has benefited the API market immensely. There is greater focus on accessibility ...

December 17, 2018 | Monday | Opinion
Big data discloses genetic behavior of brain disorders

Psychiatric disorders’ many complexities have stymied scientists looking for clear genetic culprits. But a new gia...

December 17, 2018 | Monday | News
Generex receives IND approval from FDA

Generex Biotechnology Corporation has announced that the FDA had reviewed the company’s investigational new drug (...

December 14, 2018 | Friday | News
Cambridge Heartwear launches first AI-Driven Wearable 'Heartsense monitor'

Cambridge Heartwear, a medical provider of low-cost, next-generation wearable heart monitors that uses artificial i...

December 14, 2018 | Friday | News
Amgen, Direct Relief Partner to help cancer patients In 18 countries

Amgen and Direct Relief today announced a joint initiative in which Direct Relief will distribute $93 million ...

December 14, 2018 | Friday | News
Health Canada warning: Health products by Botanicals Inc. may be harmful

Health Canada is warning that all products manufactured by Professional Botanicals Inc. may pose serious healt...

December 14, 2018 | Friday | Regulatory
Merck collaborates to develop vaccines against dengue

Merck, known as MSD outside the United States and Canada, and Instituto Butantan, Sao Paulo, Brazil, a non-profit produc...

December 14, 2018 | Friday | News
Researchers discover new compound to treat breast cancer

A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...

December 13, 2018 | Thursday | News
Key to reliable hygiene and HACCP management- MVP ICON

Most contaminants are invisible to the naked eye. Micro-organisms are fairly small, they pose a severe threat to the saf...

December 13, 2018 | Thursday | News